Please login to the form below

Not currently logged in
Email:
Password:

Portland Health adds to staff as business grows

Follows a number of new business wins for the UK agency

Julia FlintPortland Health has made a brace of new hires in response to what the London-based communications and public affairs consultancy said were 'significant new business wins'.

Joining as account director and senior account manager, respectively, are Julia Flint (pictured right) and Katie Russell. 

Flint joins from Red Health, where she spent four and a half years.  With experience in a wide range of therapeutic areas, she has advised the likes of Abbott UK, MSD, Novartis Oncology UK, Pfizer UK, Sanofi Diabetes and Johnson & Johnson. 

Flint has established extensive patient advocacy partnerships across a number of disease areas and campaigns and has delivered award-winning UK and international product and disease awareness campaigns in ethical healthcare public relations. In her new role, she will lead on healthcare media and public relations. 

Katie RussellMeanwhile, Russell, who joins Portland Health after more than three years with Insight, is a parliamentary, public affairs and campaigns specialist, with experience in endocrinology, oncology, chronic pain, haematology and sexual health.  

Working with clients including Sanofi, Bristol-Myers Squibb, Pfizer and thrombosis charity Lifeblood, Russell has successfully delivered integrated market-access and disease awareness campaigns. 

In her new role she will will take a lead on healthcare political, stakeholder and public affairs for Portland's clients.

The recruitment drive was prompted by significant new business wins over the last couple of months and a spokesperson told PMLiVE these included “a major pharmaceutical company, an international technology company targeting NHS markets, and a trade body working on the public health agenda”.

22nd August 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....